Clearline Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Sell |
6,817
-159,660
| -96% | -$5.28M | 0.01% | 106 |
|
|
2025
Q1 | $6.69M | Hold |
166,477
| – | – | 0.4% | 49 |
|
|
2024
Q4 | $7.83M | Sell |
166,477
-41,218
| -20% | -$1.94M | 1.04% | 37 |
|
|
2024
Q3 | $11M | Hold |
207,695
| – | – | 0.47% | 41 |
|
|
2024
Q2 | $11.3M | Buy |
207,695
+159,660
| +332% | +$8.65M | 0.31% | 32 |
|
|
2024
Q1 | $3.37M | Buy |
+48,035
| New | +$3.37M | 0.16% | 63 |
|